NPI: 1851329403 · CINCINNATI, OH 45206 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 06/30/2006
Authorized official SCHULTZ, DONOVAN controls 20+ related entities in our dataset. Read more
| Authorized Official | SCHULTZ, DONOVAN (PRESIDENT) |
| NPI Enumeration Date | 06/30/2006 |
Other providers sharing the same authorized official: SCHULTZ, DONOVAN
| Provider | City | State | Total Paid |
|---|---|---|---|
| DIALYSIS CLINIC INC. | JACKSONVILLE | FL | $5.57M |
| DIALYSIS CLINIC INC. | ALBUQUERQUE | NM | $4.94M |
| DIALYSIS CLINIC INC. | OMAHA | NE | $3.91M |
| DIALYSIS CLINIC INC. | SACRAMENTO | CA | $3.90M |
| DIALYSIS CLINIC INC. | PHILADELPHIA | PA | $2.95M |
| DIALYSIS CLINIC INC. | SACRAMENTO | CA | $2.60M |
| DIALYSIS CLINIC INC. | BOSTON | MA | $2.18M |
| DIALYSIS CLINIC INC. | NASHVILLE | TN | $2.11M |
| DIALYSIS CLINIC INC. | TUCSON | AZ | $1.92M |
| DIALYSIS CLINIC INC. | CORBIN | KY | $1.87M |
| DIALYSIS CLINIC INC. | GRANTS | NM | $1.69M |
| DIALYSIS CLINIC INC. | SKOWHEGAN | ME | $1.51M |
| DIALYSIS CLINIC, INC. | EAST LIVERPOOL | OH | $1.50M |
| DIALYSIS CLINIC INC. | CINCINNATI | OH | $1.50M |
| DIALYSIS CLINIC INC. | SYRACUSE | NY | $1.45M |
| DIALYSIS CLINIC INC. | NASHVILLE | TN | $1.44M |
| DIALYSIS CLINIC INC. | CHATTANOOGA | TN | $1.35M |
| DIALYSIS CLINIC, INC. | JACKSON | TN | $1.28M |
| DIALYSIS CLINIC INC. | LEBANON | TN | $1.02M |
| DIALYSIS CLINIC INC. | LEXINGTON | KY | $995K |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 24,423 | $611K |
| 2019 | 24,336 | $723K |
| 2020 | 15,051 | $556K |
| 2021 | 11,337 | $661K |
| 2022 | 8,961 | $637K |
| 2023 | 16,526 | $585K |
| 2024 | 10,191 | $515K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 59,194 | 4,873 | $4.02M |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 1,832 | 1,036 | $135K |
| J0882 | Injection, darbepoetin alfa, 1 microgram (for esrd on dialysis) | 983 | 297 | $57K |
| Q5105 | Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for esrd on dialysis), 100 units | 2,996 | 352 | $17K |
| A4657 | Syringe, with or without needle, each | 21,654 | 2,306 | $13K |
| 82108 | 198 | 189 | $13K | |
| 82728 | 1,704 | 1,598 | $10K | |
| J1756 | Injection, iron sucrose, 1 mg | 1,623 | 462 | $7K |
| J1270 | Injection, doxercalciferol, 1 mcg | 13,902 | 1,255 | $4K |
| 83970 | 1,072 | 1,004 | $4K | |
| 82310 | 329 | 223 | $4K | |
| 82040 | 193 | 139 | $3K | |
| 84100 | 458 | 346 | $2K | |
| 84520 | 306 | 133 | $1K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 106 | 104 | $849.04 |
| 84466 | 1,704 | 1,598 | $648.95 | |
| 83540 | 1,704 | 1,598 | $433.22 | |
| 90662 | 19 | 19 | $166.98 | |
| J0604 | Cinacalcet, oral, 1 mg, (for esrd on dialysis) | 327 | 38 | $140.40 |
| G0008 | Administration of influenza virus vaccine | 59 | 54 | $111.41 |
| 87340 | 41 | 36 | $14.39 | |
| 99070 | 421 | 81 | $0.00 |